This site is for US healthcare professionals to provide online access to current, accurate, scientific information about our products. It is prepared by Janssen Medical Information and is not intended for promotional purposes, nor for medical advice.

  1. Home
  2. REMICADE®

REMICADE® (infliximab)

REMICADE (infliximab)

Date Last Updated: 03/29/2022

Search this site to access the JanssenMD® Medical Information Database, or contact us by visiting askjanssenmedinfo.com or by calling 1-800-JANSSEN (1-800-526-7736), and a response will be provided promptly.

Please view the full Prescribing Information including BOXED WARNING for REMICADE (infliximab) in English.

Please view the full Prescribing Information including BOXED WARNING for REMICADE (infliximab) in Spanish.

Please view the Medication Guide for REMICADE (infliximab) in English.

Please view the Medication Guide for REMICADE (infliximab) in Spanish.

 

Clinical Trial Publications

Crohn’s Disease (CD)

TARGAN et al.

ACCENT I

PRESENT et al.

ACCENT II

REACH

Ulcerative Colitis (UC)

ACT 1 and 2

Pediatric UC

Rheumatoid Arthritis (RA)

ATTRACT

ASPIRE

Ankylosing Spondylitis (AS)

ASSERT

Psoriatic Arthritis (PsA)

IMPACT

Plaque Psoriasis (PsO)

EXPRESS

EXPRESS II

SPIRIT

Scroll to Top